BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9192445)

  • 1. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response adaptive designs with a variance-penalized criterion.
    Yi Y; Wang X
    Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Cook RJ; Willan AR
    Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.
    Willan A; Kowgier M
    Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian variable selection method for censored survival data.
    Faraggi D; Simon R
    Biometrics; 1998 Dec; 54(4):1475-85. PubMed ID: 9883546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting qualitative interaction: a Bayesian approach.
    Bayman EO; Chaloner K; Cowles MK
    Stat Med; 2010 Feb; 29(4):455-63. PubMed ID: 19950107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
    Johnson VE; Cook JD
    Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian framework for intent-to-treat analysis with missing data.
    Kleinman KP; Ibrahim JG; Laird NM
    Biometrics; 1998 Mar; 54(1):265-78. PubMed ID: 9544521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian subset analysis: application to studying treatment-by-gender interactions.
    Simon R
    Stat Med; 2002 Oct; 21(19):2909-16. PubMed ID: 12325107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly paclitaxel in the management of ovarian cancer.
    Markman M
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):37-40. PubMed ID: 10952125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.